Mast cells in melanocytic tumours

[1]  S. Galli.  New concepts about the mast cell , 1994 .

[2]  D. Schadendorf,et al.  Human mast cells produce IL-8. , 1993, Journal of immunology.

[3]  D. Schadendorf,et al.  IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.

[4]  D. Rubinstein,et al.  Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. , 1993, Cancer research.

[5]  Y. Tomita,et al.  Histologic grading in soft‐tissue sarcomas. An analysis of 194 cases including agnor count and mast‐cell count , 1993, International journal of cancer.

[6]  R. Kerbel,et al.  Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression [published erratum appears in J Cell Biol 1993 Apr;121(2):following 477] , 1993, The Journal of cell biology.

[7]  D. Schadendorf,et al.  Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype. , 1993, Melanoma research.

[8]  D. Woolley,et al.  Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. , 1991, British Journal of Cancer.

[9]  D. Morton,et al.  Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor. , 1991, Cancer research.

[10]  V. Swope,et al.  Interleukins 1α and 6 and tumor necrosis factor-α are paracrine inhibitors of human melanocyte proliferation and melanogenesis , 1991 .

[11]  I. Verlaan,et al.  Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors , 1990, The Journal of cell biology.

[12]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[13]  R. Murphy,et al.  Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. , 1989, The Journal of investigative dermatology.

[14]  H. Rockette,et al.  Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). , 1989, Human pathology.

[15]  K. Aozasa,et al.  Prognostic significance of mast cells in soft tissue sarcoma , 1988, Cancer.

[16]  J. Starkey,et al.  Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis , 1988, International journal of cancer.

[17]  E. Bröcker,et al.  Inflammatory cell infiltrates in human melanoma at different stages of tumor progression , 1988, International journal of cancer.

[18]  D. Woolley,et al.  Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma. , 1986, British Journal of Cancer.

[19]  D. Woolley,et al.  Host-mediated effectors of tumor invasion: role of mast cells in matrix degradation , 1986, Clinical & Experimental Metastasis.

[20]  W. Roche.  The nature and significance of tumour‐associated mast cells , 1986, The Journal of pathology.

[21]  G. Scapigliati,et al.  In vitro generated mast cells express natural cytotoxicity against tumour cells. , 1985, Immunology.

[22]  Roche Wr.  Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. , 1985 .

[23]  P. Askenase,et al.  The effect of histamine, antihistamines, and a mast cell stabilizer on the growth of cloudman melanoma cells in DBA/2 mice. , 1983, The Journal of investigative dermatology.

[24]  M. Mihm,et al.  Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. , 1982, Journal of immunology.

[25]  F. Hartveit.  Mast cells and metachromasia in human breast cancer: Their occurrence, significance and consequence: A preliminary report , 1981, The Journal of pathology.

[26]  D. Schadendorf,et al.  Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation , 2005, Journal of Cancer Research and Clinical Oncology.

[27]  E. Bröcker,et al.  Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype , 2004, Cancer Immunology, Immunotherapy.

[28]  H. Tritsch.  Untersuchungen über Relationen zwischen entzündlicher Infiltration, Zelltyp und Prognose beim malignen Melanom , 2004, Archiv für dermatologische Forschung.

[29]  D. Katenkamp,et al.  Untersuchungen zur prognostischen Bedeutung von Entzündungszellen in malignen Weichgewebstumoren des Menschen. Zugleich ein Beitrag zur Malignitätsgraduierung , 1992 .

[30]  V. Swope,et al.  Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. , 1991, The Journal of investigative dermatology.

[31]  S. Galli,et al.  Mast cells as a source of multifunctional cytokines. , 1990, Immunology today.

[32]  C. Garbe,et al.  Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-α on sensitive human melanoma cells in vitro may result in selection of cells in vitro may results in selection of cells with enhanced markers of malignancy , 1990 .

[33]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[34]  Y. Kitamura,et al.  Heterogeneity of mast cells and phenotypic change between subpopulations. , 1989, Annual review of immunology.

[35]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[36]  W. Roche.  Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. , 1985, The American journal of pathology.

[37]  L. de Leij,et al.  In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin. , 1983, Clinical and experimental immunology.

[38]  S. Poppema,et al.  Insitu analysis of the mononuclear cell infiltrate in primary malignant-melanoma of the skin , 1983 .

[39]  C. Hoch‐Ligeti,et al.  Association of tissue mast cells and skin tumors. , 1961, Archives of dermatology.

[40]  M. B. Sulzberger,et al.  Chloroquine for Chronic Discoid Lupus Erythematosus: Intralesional Injections , 1961 .